Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
0.0856
+0.0011 (1.30%)
At close: Dec 24, 2024, 1:00 PM
0.0850
-0.0006 (-0.70%)
Pre-market: Dec 26, 2024, 9:06 AM EST

Eyenovia Revenue

Eyenovia had revenue of $1.63K in the quarter ending September 30, 2024, with 35.64% growth. This brings the company's revenue in the last twelve months to $31.83K, up 2,557.10% year-over-year. In the year 2023, Eyenovia had annual revenue of $3.79K.

Revenue (ttm)
$31.83K
Revenue Growth
+2,557.10%
P/S Ratio
147.33
Revenue / Employee
$558
Employees
57
Market Cap
9.54M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.79K--
Dec 31, 2022---
Dec 31, 202114.00M12.00M600.00%
Dec 31, 20202.00M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Kiora Pharmaceuticals 16.02M
Mobile-health Network Solutions 13.97M
Evoke Pharma 8.62M
Evogene 7.48M
Can-Fite BioPharma 667.00K
BioCardia 71.00K
Revenue Rankings